{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:49:49Z","timestamp":1786736989343,"version":"build-2736575974"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Kidney Dis Transpl"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/1319-2442.301195","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T22:03:44Z","timestamp":1605909824000},"page":"883","source":"Crossref","is-referenced-by-count":3,"title":["Nicotinamide Therapy in Dialysis Patients: A Systematic Review of Randomized Controlled Trials"],"prefix":"10.4103","volume":"31","author":[{"given":"Anwar","family":"Habib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrish","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ThamirM","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.Sarfaraj","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd.","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AbulKalam","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1319-2442.301195-1","unstructured":"What is Chronic Kidney Disease? Available from: https:\/\/www.niddk.nih.gov\/health-information\/kidney-disease\/chronic-kidney-disease-ckd\/what-is-chronic-kidney-disease. [Last accessed on 2019 Sep 13]."},{"key":"key-10.4103\/1319-2442.301195-2","unstructured":"Treat Complication & Comorbidities. Available from: https:\/\/www.niddk.nih.gov\/health-information\/communication-programs\/nkdep\/ identify-manage-patients\/manage-ckd\/treat-complications-comorbidities. [Last accessed on 2019 Sep 13]."},{"key":"key-10.4103\/1319-2442.301195-3","unstructured":"Hyperphosphatemia. Available from: https:\/\/ www.msdmanuals.com\/professional\/endocrine-and-metabolic-disorders\/electrolyte-disorders\/ hyperphosphatemia. [Last accessed on September 13, 2019]."},{"key":"key-10.4103\/1319-2442.301195-4","first-page":"2208","volume-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.301195-5","first-page":"1119","volume-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"key-10.4103\/1319-2442.301195-6","first-page":"519","volume-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.301195-7","first-page":"51","volume-title":"A kinetic model of inorganic phosphorus mass balance in hemo-dialysis therapy","author":"Gotch","year":"2003","journal-title":"Blood Purif"},{"key":"key-10.4103\/1319-2442.301195-8","first-page":"1046","volume-title":"Postdialytic rebound of serum phosphorus: Pathogenetic and clinical insights","author":"Minutolo","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.301195-9","first-page":"862","volume-title":"Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis","author":"Delmez","year":"1982","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.301195-10","first-page":"2131","volume-title":"Association of elevated serum PO4, Ca\u00d7 PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.301195-11","first-page":"1092","volume-title":"The mechanism of phosphorus as a cardiovascular risk factor in CKD","author":"Mathew","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.301195-12","first-page":"S1","volume-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","author":"Kidney","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"key-10.4103\/1319-2442.301195-13","first-page":"225","volume-title":"Phosphate binders: New products and challenges","author":"Bellasi","year":"2006","journal-title":"Hemodial Int"},{"key":"key-10.4103\/1319-2442.301195-14","first-page":"S107","volume-title":"Control of hyperphosphatemia among patients with ESRD","author":"Coladonato","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.301195-15","first-page":"578","volume-title":"Pharmacology, efficacy and safety of oral phosphate binders","author":"Hutchison","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"key-10.4103\/1319-2442.301195-16","first-page":"1312","volume-title":"Oral phosphate binders in patients with kidney failure","author":"Tonelli","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1319-2442.301195-17","first-page":"641","volume-title":"Are we mismanaging calcium and phosphate metabolism in renal failure?","author":"Hsu","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.301195-18","first-page":"753","volume-title":"The absorption of dietary phosphorus and calcium in hemodialysis patients","author":"Ramirez","year":"1986","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.301195-19","first-page":"193","volume-title":"Magnesium carbonate for phosphate control in patients on hemodialysis.A randomized controlled trial","author":"Tzanakis","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"key-10.4103\/1319-2442.301195-20","first-page":"1115","volume-title":"Vascular calcification in chronic renal failure","author":"Goodman","year":"2001","journal-title":"Lancet"},{"key":"key-10.4103\/1319-2442.301195-21","first-page":"460","volume-title":"Reduced risk of hypercalcemia for hemo-dialysis patients by administering calcitriol at night","author":"Schaefer","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.301195-22","first-page":"21","volume-title":"Aluminium and bone disease in chronic renal failure","author":"Malluche","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.301195-23","first-page":"1239","volume-title":", Winkelmayer WC, Tonelli M.A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States","author":"Manns","year":"2004","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.301195-24","first-page":"1378","volume-title":"Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure","author":"Eto","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.301195-25","first-page":"1195","volume-title":"Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine","author":"Katai","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.301195-26","first-page":"e1000100","volume-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","author":"Liberati","year":"2009","journal-title":"PLoS Medicine"},{"key":"key-10.4103\/1319-2442.301195-27","unstructured":"Hussain S, Singh A, Habib A, Najmi A. Efficacy and safety of nicotinamide in hemo-dialysis patients: Protocol for a systematic review of randomized controlled trials. PROSPERO 2018:CRD42018093989. Available from: http:\/\/www.crd.york.ac.uk\/ PROSPERO\/ display_record.php?ID=CRD4201809. [Last accessed on October 10, 2019]."},{"key":"key-10.4103\/1319-2442.301195-28","first-page":"889","volume-title":"Research methods & reporting-the Cochrane collaboration's tool for assessing risk of bias in randomised trials","author":"Higgins","year":"2011","journal-title":"Br Med J"},{"key":"key-10.4103\/1319-2442.301195-29","first-page":"b92","volume-title":"Guidance on the conduct of narrative synthesis in systematic reviews.A product from the ESRC methods programme Version","author":"Popay","year":"2006","journal-title":""},{"key":"key-10.4103\/1319-2442.301195-30","unstructured":"Review Manager (RevMan) [Computer program]. Version 53 Copenhagen: The Nordic Cochrane Centre, The CochraneCollaboration; 2014."},{"key":"key-10.4103\/1319-2442.301195-31","first-page":"934","volume-title":"Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients","author":"Ahmadi","year":"2012","journal-title":"Saudi J Kidney Dis Transpl","ISSN":"https:\/\/id.crossref.org\/issn\/1319-2442","issn-type":"print"},{"key":"key-10.4103\/1319-2442.301195-32","first-page":"354","volume-title":"Effectiveness and safety of extended-release nicotinic acid for reducing serum phosphorus in hemodialysis patients","author":"Aramwit","year":"2012","journal-title":"J Nephrol"},{"key":"key-10.4103\/1319-2442.301195-33","first-page":"1131","volume-title":"A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients","author":"Cheng","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.301195-34","first-page":"174","volume-title":"The effect of niacin on serum phosphorus levels in dialysis patients","author":"Edalat-Nejad","year":"2012","journal-title":"Indian J Nephrol","ISSN":"https:\/\/id.crossref.org\/issn\/0971-4065","issn-type":"print"},{"key":"key-10.4103\/1319-2442.301195-35","first-page":"289","volume-title":"Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis","author":"El","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/1319-2442.301195-36","first-page":"1","volume-title":"Low dose nicotinamide as an adjunctive therapy to calcium carbonate for control of hyperphosphatemia in hemodialysis patients","author":"El-Sharkawy","year":"2013","journal-title":"Egypt J Hosp Med"},{"key":"key-10.4103\/1319-2442.301195-37","first-page":"870","volume-title":"Efficacy and safety of nicotinamide in haemodialysis patients: The NICOREN study","author":"Lenglet","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.301195-38","first-page":"58","volume-title":"Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: A double-blind randomized clinical trial","author":"Shahbazian","year":"2011","journal-title":"Nefrologia"},{"key":"key-10.4103\/1319-2442.301195-39","first-page":"562","volume-title":"The effect of oral niacinamide on plasma phosphorus levels in peritoneal dialysis patients","author":"Young","year":"2009","journal-title":"Perit Dial Int"},{"key":"key-10.4103\/1319-2442.301195-40","first-page":"239","volume-title":"Effect of low dose nicotinic acid on hyperphosphatemia in patients with end stage renal disease","author":"Zahed","year":"2016","journal-title":"Indian J Nephrol","ISSN":"https:\/\/id.crossref.org\/issn\/0971-4065","issn-type":"print"},{"key":"key-10.4103\/1319-2442.301195-41","first-page":"84","volume-title":"Niacinamideamide for reduction of phosphorus in hemodialysis and peritoneal dialysis patients.A randomized, double-blind, placebo-controlled trial","author":"Shahidi","year":"2011","journal-title":"Era Edta Congress"},{"key":"key-10.4103\/1319-2442.301195-42","unstructured":"Tayebi Kh, Etemadi J, Sephidmuy M, et al. The Effect of Nicotinamide in the Treatment of Hyperphosphatemia in Dialysis Patients; 2011."},{"key":"key-10.4103\/1319-2442.301195-43","first-page":"1099","volume-title":"Nicotinamide suppresses hyperphosphatemia in hemodialysis patients","author":"Takahashi","year":"2004","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.301195-44","first-page":"F447","volume-title":"Nicotinamide restores phosphaturic effect of PTH and calcitonin in phosphate deprivation","author":"Berndt","year":"1982","journal-title":"Am J Physiol"},{"key":"key-10.4103\/1319-2442.301195-45","first-page":"1347","volume-title":"Possible role of nicotinamide adenine dinucleotide as an intracellular regulator of renal transport of phosphate in the rat","author":"Kempson","year":"1981","journal-title":"J Clin Invest"},{"key":"key-10.4103\/1319-2442.301195-46","first-page":"e12731","volume-title":"Efficacy and safety of nicotinamide on phosphorus metabolism in hemodialysis patients: A systematic review and meta-analysis","author":"Zhang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"key-10.4103\/1319-2442.301195-47","first-page":"e0117","volume-title":"Nicotinic acid and related compounds: A meta-analysis of their use for hyperphosphatemia in dialysis patients","author":"Liu","year":"2018","journal-title":"Medicine (Baltimore)"}],"container-title":["Saudi Journal of Kidney Diseases and Transplantation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:48:36Z","timestamp":1786733316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-2442.301195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"alternative-id":["301195"],"URL":"https:\/\/doi.org\/10.4103\/1319-2442.301195","relation":{},"ISSN":["1319-2442"],"issn-type":[{"value":"1319-2442","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}